NCT03776227 A Bioequivalence Study Testing Two Formulations of Sotagliflozin in Healthy Male and Female Subjects Under Fasted Conditions Status COMPLETED Phase PHASE1
NCT03770728 Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With Sulfonylurea Status TERMINATED Phase PHASE3
NCT03769181 A Study of Isatuximab-based Therapy in Participants With Lymphoma Status TERMINATED Phase PHASE1/PHASE2
NCT03767543 Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM) Status COMPLETED Phase PHASE3
NCT03761134 Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Metformin With or Without Sulfonylurea Status TERMINATED Phase PHASE3
NCT03760991 Evaluation of the Efficacy and Safety of Insulin Glargine 300 U/mL in Patients With Type 2 Diabetes Mellitus Uncontrolled on Other Kinds of Insulin Status COMPLETED Phase PHASE4
NCT03760965 Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Diet and Exercise Status TERMINATED Phase PHASE3
NCT03757351 Study to Evaluate DNL747 in Subjects With Amyotrophic Lateral Sclerosis Status TERMINATED Phase PHASE1
NCT03746080 Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma Status COMPLETED Phase PHASE2
NCT03739268 GLP-1-mediated Gluco-metabolic Effects of Bile Acid Sequestration Status COMPLETED Phase NA
NCT03738423 Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis Status TERMINATED Phase PHASE2
NCT03736967 Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis Status TERMINATED Phase PHASE2
NCT03733717 Evaluation of Pharmacokinetics, Safety, and Preliminary Efficacy of Isatuximab in Chinese Patients With Relapsed and/or Refractory Multiple Myeloma Status COMPLETED Phase PHASE1
NCT03713684 Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s) Status TERMINATED Phase PHASE3
NCT03703869 Twelve -Month Study Observing How Insulin-naïve Patients With Type 2 Diabetes Mellitus Manage Diabetes Using Toujeo® After Oral Antidiabetic Drug Failure, the Side Effect of Toujeo®, and The Cost. Status COMPLETED Phase N/A